These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15676065)

  • 21. Comparison of lacI and lacZ transgenic mouse mutation assays: an EU-sponsored interlaboratory study.
    Tinwell H; Liegibel U; Krebs O; Schmezer P; Favor J; Ashby J
    Mutat Res; 1995 Oct; 335(2):185-90. PubMed ID: 7477049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying germ cell mutagens using OECD test guideline 488 (transgenic rodent somatic and germ cell gene mutation assays) and integration with somatic cell testing.
    Marchetti F; Aardema MJ; Beevers C; van Benthem J; Godschalk R; Williams A; Yauk CL; Young R; Douglas GR
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Aug; 832-833():7-18. PubMed ID: 30057023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo mammalian mutation assays support a nonmutagenic mechanism of carcinogenicity for hydrazine.
    Nicolette J; Murray J; Sonders P; Kondratiuk A; Crosby M
    Environ Mol Mutagen; 2021 Jan; 62(1):4-17. PubMed ID: 32951273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reporter gene transgenic mice as a tool for analyzing the molecular mechanisms underlying experimental carcinogenesis.
    Nishikawa A; Suzuki T; Masumura K; Furukawa F; Miyauchi M; Nakamura H; Son HY; Nohmi T; Hayashi M; Hirose M
    J Exp Clin Cancer Res; 2001 Mar; 20(1):111-5. PubMed ID: 11370817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mouse spot test. Evaluation of its performance in identifying chemical mutagens and carcinogens.
    Styles JA; Penman MG
    Mutat Res; 1985 Nov; 154(3):183-204. PubMed ID: 3900714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
    Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
    Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The application of the restriction site mutation assay to compare 1-ethyl-1-nitrosourea-induced mutations between the endogenous p53 gene and the transgenic LacZ gene in MutaMouse testes.
    Song HL; Jenkins GJ; Ashby J; Tinwell H; Parry JM
    Mutagenesis; 2001 Jan; 16(1):59-64. PubMed ID: 11139599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta Mouse).
    Hakura A; Tsutsui Y; Sonoda J; Kai J; Imade T; Shimada M; Sugihara Y; Mikami T
    Mutat Res; 1998 Feb; 398(1-2):123-30. PubMed ID: 9626972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pros and cons of transgenic mouse mutagenesis test systems.
    Gahlmann R
    J Exp Anim Sci; 1993 Sep; 35(5-6):232-43. PubMed ID: 8218438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial experiences and future directions for transgenic mouse mutation assays.
    Suzuki T; Hayashi M; Sofuni T
    Mutat Res; 1994 Jun; 307(2):489-94. PubMed ID: 7514722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation of CpG dinucleotides in the lacI gene of the Big Blue transgenic mouse.
    You YH; Halangoda A; Buettner V; Hill K; Sommer S; Pfeifer G
    Mutat Res; 1998 Dec; 420(1-3):55-65. PubMed ID: 9838042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice.
    Walker VE; Gorelick NJ; Andrews JL; Craft TR; deBoer JG; Glickman BW; Skopek TR
    Cancer Res; 1996 Oct; 56(20):4654-61. PubMed ID: 8840980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the mouse spot test in chemical mutagenesis: interpretation of past data and recommendations for future work.
    Russell LB; Selby PB; von Halle E; Sheridan W; Valcovic L
    Mutat Res; 1981 May; 86(3):355-79. PubMed ID: 7029265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database.
    Sasaki YF; Sekihashi K; Izumiyama F; Nishidate E; Saga A; Ishida K; Tsuda S
    Crit Rev Toxicol; 2000 Nov; 30(6):629-799. PubMed ID: 11145306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of U. S. National Toxicology Program (NTP) mouse lymphoma assay data using International Workshop on Genotoxicity Tests (IWGT) and the Organization for Economic Co-Operation and Development (OECD) criteria.
    Schisler MR; Gollapudi BB; Moore MM
    Environ Mol Mutagen; 2018 Dec; 59(9):829-841. PubMed ID: 30357906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A selectable system for mutation detection in the Big Blue lacI transgenic mouse system: what happens to the mutational spectra over time.
    Knöll A; Jacobson DP; Nishino H; Kretz PL; Short JM; Sommer SS
    Mutat Res; 1996 Jun; 352(1-2):9-22. PubMed ID: 8676922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel lacI transgenic mutation-detection system and its application to establish baseline mutation frequencies in the scid mouse.
    Andrew SE; Pownall S; Fox J; Hsiao L; Hambleton J; Penney JE; Kohler SW; Jirik FR
    Mutat Res; 1996 Oct; 357(1-2):57-66. PubMed ID: 8876680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of shuttle vectors for mutation analysis in transgenic mice and rats.
    Dycaico MJ; Provost GS; Kretz PL; Ransom SL; Moores JC; Short JM
    Mutat Res; 1994 Jun; 307(2):461-78. PubMed ID: 7514720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-mammal mutagenicity tests: evaluation of five methods.
    Russell LB; Matter BE
    Mutat Res; 1980 May; 75(3):279-302. PubMed ID: 6991917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.